ArticleAlimentary pharmacology & therapeutics2019

The effectiveness and safety of infliximab compared with biosimilar CT-P13, in 3112 patients with ulcerative colitis.

Antoine Meyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.